NASDAQ:CTIC

CTI BioPharma Corp Earning Date

USA |NASDAQ |USD

CTIC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.25 $-0.21 $-0.15
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $0.00 $0.00 $0.00

Cti Biopharma Corp's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

CTIC Earnings Date & History Chart

CTIC Earnings & Revenue Forecast

CTIC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.18 $-0.49 $0.20
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.86 $-1.32 $-0.44
Dec 2022 6 $-0.54 $-1.21 $0.60

CTIC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.18 $-0.27 $-0.27
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.86 $-0.94 $-0.94
Dec 2022 0 / 0 $-0.54 $-0.43 $-0.43

CTIC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $13.57M $0.00 $61.10M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $13.57M $0.00 $61.10M
Dec 2022 6 $62.49M $21.00M $137.02M

CTIC Earnings Date & Revenue History

CTIC Earnings History

|
Show More
Show More

CTIC Revenue History

|
Show More
Show More

Cti Biopharma Corp Next Earnings Date & Report

CTIC Next Earnings Date & Report Preview: Sep 2021 (FQ)

CTIC's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Cti Biopharma Corp's next quarterly earnings is $-0.25, with a low EPS estimation of $-0.37, and a high estimation of $-0.21.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.25, the last 2 month trend is $-0.24, and the 3 month trend is $-0.24.

Based on 6 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Cti Biopharma Corp Previous Earnings Dates & Reports

CTIC Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cti Biopharma Corp's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

CTIC's earnings per share (EPS) was $-0.21.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -8.70%, and lower than the same period a year before (Jun 2020) by 10.53%.

Revenues were $0.00.

The company reported a net income of $-19.68M.

Free cash flow for the quarter was $-34.37M , compared to $-16.78M last quarter and $-9.57M a year before.

CTIC ended the quarter with $2.05M in total debt, a decrease of -62.95% compared to the previous quarter, and a decrease of -70.14% compared to the same quarter a year before.

CTIC Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cti Biopharma Corp's previous annual earnings date was Mar 17, 2021 for its fiscal year ended Dec 31, 2020.

CTIC's earnings per share (EPS) was $-0.74, missing the consensus analysts forecast of $-0.69 by 7.25% , and lower than the previous year's EPS (Dec 2019) by 7.25%.

Revenues were $4.20K.

The company reported a net income of $-52.45M.

Cti Biopharma Corp reported a free cash flow of $-42.22M for its fiscal year, compared to $-27.82M a year ago.

The company ended the fiscal year with $8.91M in total debt, a decrease of -3.85% compared to the previous year.